All posts by medical

International Peace Prize awarded to Ascension St. Mary’s executive director – Midland Daily News

Gary L. Dunbar, executive director of the Field Neurosciences Institute, part of Ascension St. Mary's, was recently presented with the Gusi Peace Prize International Award.

Dr. Dunbar recently traveled to Manila, Philippines to accept this honor at the Gusi Peace Prize International 20th Annual Awards Night.

The Gusi Peace Prize award is given by the Gusi Peace Prize Foundation to recognize individuals and organizations who contribute to global peace and progress through a wide variety of fields. Dunbar was one of 18 international recipients selected for the award and chosen because of his global contributions in both the educational and the research domains of neuroscience. Similarly, his contributions in research, especially for developing new strategies for treating damage to the nervous system, including transplantation of genetically altered adult stem cells as a potential therapy for injury to the brain and spinal cord as well as neurological deficits in Huntington's, Parkinson's and Alzheimer's diseases, has earned international recognition and a prominent leadership role in the American Society for Neural Therapy and Repair.

"I felt both honored and humbled to be selected for the Gusi Peace Prize, especially after meeting and hearing, first-hand, what the other 2019 Gusi Laureates have accomplished in the context of helping others, which was humbling to me," shared Dunbar. "The prize is given to those whose efforts have provided significant improvements to the lives of others through education, research, politics, and/or the arts, along with a strong commitment to humanitarian commitments, so I felt deeply honored to be included in this group of people."

Dunbar has been the executive director for the Field Neurosciences Institute since 2008. Martha Ann Joseph, Chair of the institute's board of directors, was thrilled to hear that Dunbar was a recipient of the Gusi Peace Prize International Award.

"(Field Neurosciences Institute) is blessed to have Dr. Dunbar as our executive director for the past 11 years as he has always embraced the mission of the organization, to help others in terms of preventing brain injury and searching for cures for neurological problems emanating from trauma and disease to the nervous system," Joseph said.

"Dr. Dunbar embodies the very premise of the Gusi award in attaining peace and dignity for fellow humans by his tireless devotion to finding new ways to treat a variety of neurological disorders and for his dedicated efforts in educating the next generation of neuroscientists, physicians, and health-care providers at the highest level," added E. Malcolm Field, Field Neurosciences Institute director.

Presently, Dunbar holds the John G. Kulhavi Professorship in Neuroscience, as well as the E. Malcolm Field Endowed Chair in Neuroscience at CMU.

The Gusi Peace Prize was founded by the Honorable Ambassador Barry Gusi, to honor and continue the work of his late father, Captain Gemeniano Javier Gusi, who fought against Japanese oppression during World War II and later championed human rights in the Philippines. For 20 years, the Gusi Peace Prize Award has been awarded to prominent individuals from all over the world who have made significant contributions to the betterment of humankind.

See the article here:
International Peace Prize awarded to Ascension St. Mary's executive director - Midland Daily News

How to bring precision medicine into the doctor’s office – World Economic Forum

Are you one of the 26 million people who have experienced genetic testing by companies such as 23andMe or Ancestry? These companies promise to reveal what your genes say about your health and ancestry. Genes are, indeed, the instruction book containing the code that makes you a unique human being. This specific code which you inherit from your parents is what makes you, you.

The genetic coding system works amazingly well, but like all systems, occasionally things dont go as planned. You may inherit a gene that increases your chance of developing a health condition and sometimes the code develops an error causing you to have a devastating disease.

If genetic testing is so powerful in analysing and understanding your health, why cant you just as easily have this same genetic information inform your care at the doctors office? To answer this question, lets first look at the field of using genetic information to drive your healthcare (often referred to as precision or personalized medicine).

Across the globe, researchers devote enormous amounts of time and effort to understand how human genes impact health and billions of dollars are invested. The knowledge of what impact specific genes have on our health has increased tremendously and continues to do so at an amazing pace. Our increased understanding of genes, and how they affect our health, is driving novel methods to halt diseases and new ways of thinking about how medications can be developed to treat diseases.

Precision medicine is a growth area

With all this money and effort being expended, why isnt the use of your genetic information a standard part of your medical care? As the Kaiser Permanente Fellow to the World Economic Forums Precision Medicine Team, I recently had the opportunity to interview leaders from every aspect of Precision Medicine to understand the barriers preventing genetic testing from becoming a standard part of your healthcare.

Those with whom I spoke included insurance companies who pay for the tests, doctors who use and interpret them, genetic counsellors who help you understand test results, diagnostic companies which develop testing, government healthcare regulators, researchers making astonishing discoveries and healthcare organizations who are determining how best to deploy genetic testing.

These interviews suggest that the science behind genetic testing and the knowledge of how genes impact health is far ahead of our ability to make full use of this information in healthcare. Moving genetic testing into your doctors office requires a complex set of technologies, processes, knowledge and payments. Though many of the barriers inhibiting this movement were unique and complex, there were some consistent and common themes:

1. The limited expertise in genetics within healthcare systems. The need for education of healthcare providers as well as the public was regularly highlighted. The use of genetics in healthcare requires specialized knowledge that is outside the expertise of most doctors. Healthcare providers simply dont have time to study this new and rapidly changing information as their hands are full just keeping up with the latest trends and findings in their specialities. Additionally, education on genetics in healthcare is needed for the public. As one person interviewed said: The public watches CSI and thinks the use of DNA and genetics is black and white; using genetics in healthcare is rarely black and white

2. The lack of sufficient genetic counsellors. Genetic counsellors are often used to engage patients prior to testing and after results have been received, providing them with the detailed and nuanced information required for many of these tests. They also support doctors when they need assistance in making decisions about genetic testing and understanding the test results.

3. To successfully embed genetics into your care, doctors need the workflows for genetic testing (receiving results and understanding the impact on their care plans) to become a seamless part of their work. Clinical decision support software for genetics should alert the healthcare provider when genetic testing is merited with a patient, based on information the provider has entered during their examination. The software should then provide a list of appropriate tests and an explanation of why one might be used over another. After doctors order the test, they believe is most appropriate, the system should inform them of the results in clear, easily understandable language. The results should inform the doctor if the care plan for this patient should be modified (with suggestions for how the care should change).

4. Coverage of payments for genetic testing. If such tests are not paid for by insurers or government healthcare agencies (the payers), doctors simply wont order them. In the US and many other countries, there is patchwork coverage for genetic testing. Some tests are covered under specific circumstances, but many are not covered at all. The major reason cited by the payers for not covering genetic testing is a lack of evidence of clinical efficacy. In other words, do these tests provide actionable information, that your doctor can use to ensure better health outcomes? Until the payers see sufficient evidence of clinical efficacy, they will be hesitant to pay for many types of genetic testing. Doctors are concerned about the same thing, according to my research. They want to see the use of these tests in large populations, so they can determine that there is a benefit to using them.

Using your genetic information in healthcare is much more complex than taking a direct-to-consumer genetic test such as those offered by 23andMe. Healthcare is a multifaceted system and doctors already have too much on their plate. As such, there must be sufficient proof that the use of genetic testing will result in better health outcomes for the populations these clinicians serve before it's introduced into this setting.

We cannot hesitate in the face of the above complexities. As I completed the interviews which revealed these barriers, I stumbled across a journal article on this very subject. Written by a prominent group of doctors and researchers from government and leading universities in 2013, it highlights these same barriers and that virtually no progress has been made in the ensuing seven years. This is why I am focusing my fellowship at the World Economic Forum on a new project called Moving Genomics to the Clinic. Taking advantage of the multistakeholder platform of the Forum, the project will quicken the pace of tackling these barriers so that the use of genetic information can become a standard part of your healthcare experience.

License and Republishing

World Economic Forum articles may be republished in accordance with our Terms of Use.

Written by

Arthur Hermann, Fellow, Precision Medicine, World Economic Forum

The views expressed in this article are those of the author alone and not the World Economic Forum.

Continue reading here:
How to bring precision medicine into the doctor's office - World Economic Forum

Air Pollution Is Breaking Our Hearts: Particulate Matter Leads to Thousands of Deaths per Year – SciTechDaily

Air pollution is associated with detrimental effects on human health, including increased risk of heart disease and stroke. Research published today (December 15, 2019) in The Journal of Physiology by researchers at The University of Manchester shows that the knowledge we have about how pollution harms the hearts of marine species can be applied to humans, as the underlying mechanisms are similar. In other words, knowledge gained from the marine ecosystem might help protect the climate and health of our planet, whilst also helping human health.

Around 11,000 coronary heart disease and stroke deaths in the UK each year are attributable to air pollution, specifically due to particulate matter (PM), or small particles in the air that cause health problems. PM2.5 is one of the finest and most dangerous type of PM, is a compound for which the UK has failed to meet EU limits.

Researchers of this study looked across all vertebrates and particularly focused on a set of compounds that binds to the surface of PM, called polycyclic aromatic hydrocarbons (PAH) as the amount of PAH on PM is associated with the detrimental affect air pollution has on the heart.

While air pollution is known to be dangerous to humans, it actually only became a widely-researched topic in the past five years or so. In marine species, however, the mechanism of how PAH pollution causes heart problems is well understood.

Studies after the 1999 Exxon Valdez oil spill showed that the ecosystem still has not recovered 20 years on. In 2010, research on fish after the Deepwater Horizon oil spill, which released large quantities of PAHs into the marine environment, showed that the hearts ability to contract was impaired.

Dr. Holly Shiels, senior author on the study, from The University of Manchester said:

Pollution affects all of us living on Planet Earth. Due to the conserved nature of cardiac function amongst animals, fish exposed to PAH from oil spills can serve as indicators, providing significant insights into the human health impacts of PAHs and PM air pollution.

Dr. Jeremy Pearson, Associate Medical Director at the British Heart Foundation, which partly funded the research presented in this review, commented:

We know that air pollution can have a hugely damaging effect on heart and circulatory health, and this review summarises mechanisms potentially contributing to impaired heart function. Reducing air pollution is crucial to protecting our heart health, which is why the BHF is calling on the next Government to commit to reducing air pollution to within WHO limits.

Reference: Polyaromatic hydrocarbons in pollution: A heartbreaking matter by C. R. Marris, S. N. Kompella, M. R. Miller, J. P. Incardona, F. Brette, J. C. Hancox, E. Srhus and H. A. Shiels, 15 December 2019, The Journal of Physiology.DOI: 10.1113/JP278885

Continued here:
Air Pollution Is Breaking Our Hearts: Particulate Matter Leads to Thousands of Deaths per Year - SciTechDaily

Why are female test subjects still being excluded from exercise research? – The Globe and Mail

The criticism from an anonymous peer reviewer caught Matthew Heath by surprise.

The University of Western Ontario kinesiology professor had submitted a study on the cognitive benefits of exercise, involving seven men and five women. But the inclusion of women, the reviewer argued, was a mistake, due to cognitive and physiological differences in the menstrual cycle. To avoid this complication, women should have been excluded from the study.

Heath disagreed so he decided to investigate this claim. In a study published last month, Heath, undergraduate research student Kennedy Dirk and kinesiology professor Glen Belfry tested the effects of exercise on cognition in women at different stages of their menstrual cycles.

Story continues below advertisement

The results, which appear in the journal Medicine & Science in Sports & Exercise, found no differences linked to hormonal fluctuations. Thats good news for Heath (whose original study was eventually published despite the reviewers objections), but it highlights a continuing challenge in exercise research: An overwhelming number of studies either omit women completely or make the mistake of assuming that women are, as physiologist Stacy Sims puts it, simply small men.

The new study involved 15 female subjects who did 20 minutes of moderate cycling, preceded and followed by a test measuring executive function, which involves cognitive processes such as working memory and attentional control. They repeated this process once during the early follicular phase of their menstrual cycle, when estrogen and progesterone levels are at their lowest, and once during the midluteal phase, when theyre elevated. Performance on the cognitive test increased after exercise by the same amount in both tests.

The idea that hormonal changes might influence cognitive function isnt totally unfounded, Heath points out. A review of the relevant literature by Swedish researchers in 2014 suggested that emotional processing may change across the menstrual cycle, but concluded that such differences were small and difficult to replicate hardly a good reason to exclude women from studies of this type.

That doesnt, however, mean that men and women are interchangeable in all exercise studies. On average, men tend to be bigger and heavier than women, have different distributions of muscle-fibre type and patterns of fat storage, and respond to physical stresses in slightly different ways.

For example, a study published this month in Sports Medicine by University of Calgary researchers Candela Diaz-Canestro and David Montero analyzed previous research comparing how men and women respond to endurance training. For a given level of training, they found that men seem to get a slightly bigger boost in VO2max, a measure of aerobic fitness. On the other hand, women seemed to get a greater boost in lifespan from increasing their VO2max by a given amount.

These differences are subtle, but they do exist. And the solution, Heath and others argue, isnt to exclude women from studies its to include them, and where relevant analyze the results separately to look for differences.

The U.S. National Institutes of Health, the worlds largest funder of biomedical research, has mandated the inclusion of both men and women in clinical trials since 1994, points out Brock University doctoral researcher Kate Wickham. But attitudes such as those of Heaths anonymous reviewer remain surprisingly common.

Story continues below advertisement

When Wickham set out to explore the performance-boosting effects of nitrate-rich beet juice during her masters degree at the University of Guelph, she found more than 100 studies on the topic that features all-male subject populations. In comparison, there were just seven all-female studies.

Based on the extremely limited data available, it seems that women may actually get a bigger endurance boost from beet juice than men. But its not clear whether that reflects some subtle difference in physiology or whether its simply a result of women typically being smaller than men (and thus getting a higher nitrate dose from a bottle of beet juice), or the fact that women tend to eat more nitrate-rich foods such as spinach and arugula.

The bottom line is that we dont know the answer to these and many other questions and we wont until research that includes both men and women is not just accepted but expected.

Alex Hutchinson is the author of Endure: Mind, Body, and the Curiously Elastic Limits of Human Performance. Follow him on Twitter @sweatscience.

Live your best. We have a daily Life & Arts newsletter, providing you with our latest stories on health, travel, food and culture. Sign up today.

Follow this link:
Why are female test subjects still being excluded from exercise research? - The Globe and Mail

Organs-on-chips Market Competitive Landscape Analysis with Forecast by 2025 – Techi Labs

Organs-on-chips or organ-on-a-chip is an electronic gadget that consists of a 3D microfluidic cell culture-based multi-channel structure. This gadget essentially is a chip that can control mechanisms, activities, and physiological responses of organs and organ systems, after being implanted in the body. In a more simplistic manner, this chip acts mainly as an artificial organ, or an artificial system that undertakes processes controlled by human bodies in a natural state. A brisk rise in research in the field of biomedical engineering, particularly to find alternatives for replacing failed human organs has formed a distinct organs-on-chips market.

This market is being pushed to attain substantial growth owing to a rise in healthcare industry applications. Surging cases of organ failure in the form of liver, kidneys, lungs, and heart also are prime reasons for fueling the search to find viable alternatives.

Get Report Sample Copy @https://www.tmrresearch.com/sample/sample?flag=B&rep_id=3098

The bioelectronics components are mainly created on small microchips, which have tin chambers formed by living cells. These cells are arranged in such a manner that they mimic human body physiology on a micro-level scale. These simulations are utilized on a macro scale by enhancing them with the help of various methods. According to the organs mentioned above, there are separate chips made for each organ, and even for some smaller constituents that make up an organ. For example, heart-on-a-chip, skin-on-a-chip, artery-on-a-chip, lung-on-a-chip, and kidney-on-a-chip are key organ-on-a-chip gadgets that are being extensively used. Installation of each of these chips depends on several factors such as body acceptability, medical condition of patient, and physiological responses, among others.

Organs-on-chips Market: Overview

Organ-on-chip is multichannel 3D micro-fluidic cell culture gadget, which prompts mechanisms, activities, and physiological reflexes of human organs. This chip builds up a thin channel for the air and blood flow in organs including gut, lung, heart, liver, and so on. This gadgets is created on a microchip, which has constantly perfused chambers made by living cells arranged in a way to invigorate tissue- level physiology and organ-level physiology. It is utilized to sustain interior organs with the support of silicone.

The worldwide organ-on-chip market is fragmented based on geography and type. On the basis of type, the market is partitioned into human-on-chip, heart-on-chip, lungs-on-chip, intestine on-chip, liver-on-chip, and kidney-on-chip. Based on geography the organs-on-chips market is segmented into Europe, North America, Asia-Pacific, Latin America, and the Middle East and Africa.

The analysts of the report have utilized skilled procedures to anticipate the patterns in the market for organs-on-chips keeping in mind the end goal to make precise projections. The examination of different market components has been utilized to illustrate noteworthy, current, and provisional future patterns, which would enable the market players to get a domain of the market.

Organs-on-chips Market:Trends and Prospects

The development of the global organ-on-chip market is driven by rise in its applications in the healthcare industry, increase in demand for drug screening, and soaring demand for kidney applications and lung-based organ culture. Be that as it may, high cost and early stage in research and development obstruct the market development. These components are expected to either drive or hamper the market. But, nevertheless, rise in research processes on organ-on-chips is estimated to offer plenty of opportunities for the leading players.

Deficiency of donor lungs for transplantation has prompted increase in number of patients dying due to illness. In this way, increase in demand to create lab-engineered, functional organs is expected to supplement the development of the market. Recellularized strong organs can perform organ-specific tasks for limited amount of time, which shows the potential for clinical utilization of artificially designed strong organs later on.

Rise in demand for organ-on-chip gadgets in the medical industry is foreseen to help the development of the global market. Organ-on-chip gadgets are known to be useful in in-vitro analysis of biochemical, real-time imaging, and metabolic and genetic activities of living cells in a functional tissue, which majorly boost their adoption.

Request TOC of the Report @https://www.tmrresearch.com/sample/sample?flag=T&rep_id=3098

Drug screening is a practical technique utilized for quickly reviewing samples. Researchers and analysts utilize organ-on-chips culture gadgets to monitor the impacts of medications in the body. Moreover, drug effectiveness or drug toxicity in different organs of the body is checked utilizing this procedure, which helps the market development.

Organs-on-chips Market:Regional Outlook

The heart-on-chip segment has higher potential for development in the global market. Lung-on-chip led the global organ-on-chip market in 2016, and is anticipated to continue its predominance within the forecast period. North America held the biggest market share, because of advanced technological innovations and rise in healthcare applications. Asia-Pacific is expected to witness the most astounding development due to various growth opportunities offered by nations, for example, India, China, and Japan. The accessibility of new and advanced organs-on-chips in the market, and ideal government activities as far as financing and projects for essential drug advancement and research, and the advent of key pharmaceutical organizations. These are regions where the lions share of drug development activity is focused.

Organs-on-chips Market:Vendor Landscape

Emulate, Inc., CN Bio Innovations, Ascendance Biotechnology, Inc., Mimetas B.V., Organovo Holdings, Inc., Tara Biosystems, AxoSim Technologies LLC, Hurel Corporation, Insphero AG, and Nortis Inc. are among the major players in the global organs-on-chips market.

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

View post:
Organs-on-chips Market Competitive Landscape Analysis with Forecast by 2025 - Techi Labs

Research at the ends of the earth – AAMC

Think biomedical research and you may envision test tubes, microscopes, and rows of petri dishes. But for some scientists, conducting research instead means strapping on scuba gear, scaling the slopes of Mount Everest, joining foraging tribes on a South Asian hillside, or embarking on other equally remote adventures. Sometimes, the work involved is uncomfortable or downright dangerous. But these researchers say it also can be exhilarating to advance medical knowledge in ways that arent feasible without such severe conditions or far-flung treks.

Here are profiles of several scientists who went to extremes, not just for a change in scenery, but because as Martin Cetron, MD, an Emory University School of Medicine professor and supervisor at the Centers for Disease Control and Prevention (CDC), says Thats where you had to go to do the work.

It was a simple question. During a presentation, Richard Moon, MD, a professor of anesthesiology and medicine at Duke University School of Medicine, was asked, Why study people at high altitudes?

Moon, who also directs Dukes Hyperbaric Center, recited a boilerplate explanation: At high altitudes, blood oxygen concentrations are often far below normal. This potentially dangerous condition, called hypoxia, also crops up in medical contexts from anesthesiology to critical care.

As Moon sat down, a colleague leaned over to critique his answer. What you should have said is that [at high altitudes] people expose themselves voluntarily to degrees of hypoxia that no human experimentation committee would ever allow.

That, Moon concedes, was right. Im sure if I went to the Duke Institutional Review Board and proposed lowering peoples oxygen saturation to below 60%, it would never be approved. But on our Everest trek we found that people were at that level all the time.

In 2013 and again in 2017, Moon and several Duke colleagues took advantage of an opportunity to join Mount Everest hikes organized by British scientists, where they would study high-altitude trekkers under field conditions.

One of the questions that is very important clinically is how low can you go in blood oxygenation without causing serious damage, Moon explains.

During his recent trek, Moon asked fellow hikers to strap on a pulse oximeter a watch-like devicewith a probe that connects to the wearers finger or forehead so he could monitortheir oxygen saturation. He instantly had more subjects than he could stuff into a hyperbaric chamber.

Several hikers were treated for acute mountain sickness and altitude-related cerebral edema, but others suffered no serious problems. At the highest camp, at an altitude of more than 18,000 feet, Moon recorded his own lowest reading: below 60% oxygen saturation. Others recorded even lower readings, Moon noted, which, if seen in any of our hospital patients, would elicit panic. Now, he believes, low levels in some circumstances may not be as dangerous as once thought.

Also on Moon's agenda has been recruiting volunteers primarily mountaineering guides for a project with British investigators on epigenetic changes in people whose bodies adapt to the lower oxygen levels of high altitudes.

Imagine if we had a drug that could induce that adaptation, says Moon. If patients needing oxygen treatments could manage with lower levels, they might avoid some of the treatments risks, which include nerve, eye, and lung damage. For people who are in the ICU with lung failure, we wouldnt have to give them as much oxygen,he notes. "What a huge advance that would be.

To better understand how human physiology from brain function to the gut microbiome responds in a pressurized environment, Dominic DAgostino, PhD, dove 62 feet beneath the surface to an undersea laboratory called the Aquarius Reef Base, off Key Largo, Florida.

DAgostino is an associate professor of molecular pharmacology and physiology at the University of South Florida Morsani College of Medicine. A trained diver, his research interests include how to prevent oxygen toxicity seizures, which can occur when a person breathes concentrated oxygen. The seizures threaten patients undergoing hyperbaric therapy for such medical issues as decompression sickness and wounds that wont heal and they can be fatal.

As DAgostino dove deeper literally and figuratively into physiology in extreme environments, he met NASA workers who replicate the weightlessness of space by going under water. Those connections got him invited on a 2017 NEEMO (NASA Extreme Environment Mission Operations) mission to the Aquarius lab, which is run by Florida International University.

I was about jumping out of my skin and pinching myself. I wanted to incorporate as much science as possible into that mission, DAgostino says.

After strapping on scuba gear, the crew members swam down to Aquarius and popped up in a chamber where trapped air prevented the sea from rushing in. The air is more than twice as dense as at sea level, explains DAgostino. You feel it when youre breathing it, and you feel it when you talk.

For ten days, the crew followed a packed schedule. We would do about half the science inside the habitat and about half outside, DAgostino explains. Among his tasks was collecting data on pressure-related changes in sleep, skin microbiomes, metabolic markers, strength, and decision-making.

The work, which included studying their own bodies under demanding conditions, was worth the effort, DAgostino notes. I can say without reservation that the NASA NEEMO mission was the most intense, amazing experience of my life, he says. Its the only habitat really in the world that can allow us to do this kind of science.

One day, while studying the gut microbiome in rural tribes in Nepal, Aashish Jha, PhD, was apportioning human waste into glass vials. A villager expressed concern. She knew he had gone to college for many years. If we send our children to college, will they have to do something like this also? she asked.

But Jha, a post-doctoral researcher at the Stanford University School of Medicine, was delighted to spend many months collecting stool samples.

For the stint in 2016, Jha selected several tribes far from major roads and markets. All had been nomadic hunter-gatherers, but some had changed over time. The Tharu, for example, had developed agriculture about 300 years ago, and the Raji had begun farming more recently. The Chepang were the hardest to reach. Still foraging wild fruits and vegetables, they lived on a barren hill accessible only by four-wheel drive.

Because these tribes were exposed to similar bacteria in a close geographic area, and because their lifestyles diverged only recently, they provided very nice comparison groups to understand how the human gut microbiome deviates from a traditional foraging type as humans move closer and closer to agriculture, says Jha.

A stranger asking for human waste might be a difficult sell, but Jha worked with anthropologists and others who already had ties with the groups.

The concept of microscopic bugs in the digestive tract wasnt very difficult to explain. It wasnt that foreign a concept for people, because people in Nepal get helminth infections all the time, Jha says. Helminths are visible parasitic worms. So when we tell them there are little tiny bugs in their gut, they think of helminths.

Jha found that the villagers microbiomes lined up on a very nice gradient of microbial shift, with the foraging Chepang at one end and the agricultural Tharu at the other. Bacterial species common in foragers were scarce or nonexistent among farmers and vice-versa. Many of the bacteria found among the tribes were absent from the American microbiome, which is representative of people who rely on industrial agriculture.

Jha hopes that additional studies will clarify the possible role of missing bacteria in conditions such as irritable bowel syndrome, rheumatoid arthritis, and celiac disease that appear to be mediated by the microbiome.

A big question is what role the missing bacteria play. Whether they are medically relevant, we dont know, says Jha. That is the next step that we are exploring.

As a professor of emergency medicine at the University of Colorado School of Medicine, Ben Easter, MD, is, quite naturally, concerned about emergencies.

But the emergencies that most interest Easter will occur on Mars.

To help anticipate problems that humans could encounter on the red planet, Easter works at the Mars Desert Research Station, located in a barren stretch of Utah he describes as absolutely Martian. There he dons a spacesuit, communicates via a radio in his helmet, and leads students, physicians, and engineers in simulated life-and-death struggles on week-long missions. Since 2015, Easter has led a half-dozen courses at the station, which is run by the nonprofit Mars Society.

Ive always been interested in space, long before I ever wanted to be a doctor, he says.

The Mars crew lives in a habitat equipped with solar panels, a research dome for lab work, and electric vehicles for traveling outside. They periodically pull on spacesuits, sit patiently in a simulated airlock, and exit the station for extravehicular activities, such as collecting soil samples.

But sometimes someone often Easter suddenly comes sliding down a rocky outcrop feigning a broken limb and bearing a tear in his spacesuit thats gushing oxygen.

So the group has to find and isolate the leak and patch the leak to prevent the person from getting decompression sickness. In addition to taking care of the suit, they have to figure out how theyre going to evacuate their injured crew member back to the habitat, says Easter. The amazing thing is how much we were able to create scenarios where the crew really buy into their environment.

The Mars simulations provide a helpful supplement to Easters other work as a researcher at Johnson Space Center, where he uses mathematical models to anticipate extraterrestrial emergencies. But Easter most values the missions chance to educate and inspire.

Weve had some of our students and physicians significantly alter their careers to pursue work in space medicine or a space industry-related field, he says. Being able to put together a week-long course that people are really excited about and then give them that spark to change what theyre doing with their life and pursue something that they really enjoy, I think thats what Im most proud of.

Among his research efforts, Martin Cetron, MD, developed field tests in southern India for the early diagnosis of leprosy and collaborated with local teams in northeastern Brazil to uncover the source of a protozoan that was causing the sometimes fatal disease leishmaniasis.

Along the way, he contracted intestinal diseases, malaria, and schistosomiasis, which he calls a poignant reminder of the connection between field research and the patient experience.

But a bit of medical detective work for the CDC in Africas Lake Malawi in 1992 changed the course of his career.

I thought I was coming here for a two-year stint to learn more about parasitic infections from the worlds experts and would go back to an academic research and clinical career, he says.

Instead, he found himself solving mysterious instances of schistosomiasis, which is caused by a snail-based parasitic flatworm. The cases involved a complex, tangled story: After drought ravaged corn crops, desperate villagers turned malaria bed nets into fishing gear, and they then overfished a predator that usually reduces the snail population. Cetron ultimately discovered that 90% of village schoolchildren had been infected without anyone realizing.

He marvels at the irony that the intended public health intervention of bed nets to prevent hyperendemic malaria enabled the schistosomiasis epidemic. I was so dumbfounded that I spent the rest of my working life at CDC exploring the intersection of pathogens, hosts, human behavior, and the environment.

Cetron is now director of the CDC Division of Global Migration and Quarantine and an adjunct associate professor at the Emory University School of Medicine. His work involves overseeing several international efforts, including a project that detects disease outbreaks by collecting data from a network of clinics that serve international travelers. Human migration is complex and challenging in the context of disease emergence and spread, says Cetron. When it comes to germs, he notes, travelers are essentially sampling the world.

Networks allow much surveillance to be done from afar, but if a disease is particularly worrisome or complex, Cetron will dispatch a field team.

Among the newsworthy epidemics he and his staff have investigated are the H1N1 influenza pandemic of 2009, Ebola outbreaks from 2014 to the present, and the 2015 Zika virus outbreak.

You need to have a global surveillance network that provides eyes and ears and is constantly taking the pulse of whats happening out there in a world that is highly mobile and interconnected, he says. Those networks are much bigger, more robust, and more enduring than what any one individual can do alone.

Follow this link:
Research at the ends of the earth - AAMC

Research finds key reason why brain connectivity goes awry in rare neurodevelopmental conditions – News-Medical.net

Axons are the long thread-like extensions of neurons that send electrical signals to other brain cells. Thanks to axonal connectivity, our brains and bodies can do all necessary tasks. Even before we're born, we need axons to grow in tracts throughout gray matter and connect properly as our brains develop. UNC School of Medicine researchers have now found a key reason why connectivity goes awry and leads to rare but debilitating neurodevelopmental conditions.

Published in the journal Developmental Cell, researchers led by Eva Anton, PhD, professor of cell biology and physiology at UNC-Chapel Hill, show how two gene mutations alter the function of neuronal cilia - antennae-like protuberances found on many cell types. The resulting dysfunctional cilia affect axonal connectivity and leads to rare Joubert syndrome-related disorders (JSRD).

"Our experiments demonstrate that ciliary signaling facilitates appropriate patterns of axon tract development and connectivity," said Anton, who is a member of the UNC Neuroscience Center. "Disrupting ciliary signaling can lead to axonal tract malformations in JSRD."

Although cilia are found on most cell types, their significance in brain development, has been largely underappreciated, until recently.

Scientists now know that cilia sense the environment around them, and dysfunctional cilia mess up axonal growth and connectivity during fetal development. Babies born with dysfunctional cilia and associated irregular axonal growth and connectivity can develop JSRD. Molar tooth sign, a characteristic defect of axonal projections detectable in brain MRI images, is often used to diagnose JSRD. People with the condition experience developmental delays, intellectual disabilities, abnormal respiratory rhythms, trouble controlling their body movements, and other serious health issues. But how this happens has not been clear.

Using neuron-specific mouse genetic models of two genes called Arl13b and Inpp5 and related human mutations from JSRD patients, as well as chemo-genetic and opto-genetic manipulation of primary cilia signaling, Anton and colleagues investigated how cilia become dysfunctional and affect axonal connectivity during brain development.

In mice, they found that deletion of Arl13b or Inpp5e impairs the ability of the primary cilium to function as a signaling hub, thus allowing them to examine how cilia-driven signaling regulates axon growth and connectivity in normal and JSRD brains. Anton and colleagues went on to delineate ciliary-driven changes in cell signaling, particularly the ones mediated through major signaling proteins PI3K AKT, and AC3 effectively modulate axonal behavior.

Before this research, the significance of primary cilia in the emergence of brain connectivity were undefined. Nor did the research community understand exactly how cilia dysregulation led to axonal tract defects in Joubert syndrome-related disorders.

By shedding light on the significance of primary cilia in the emergence of brain connectivity, this research helps us understand how cilia dysregulation led to axonal tract defects in Joubert syndrome-related disorders. Our studies indicate precise manipulation of ciliary signaling in the future may be tested and utilized to alleviate neuronal connectivity defects in ciliopathies, such as JSRD."

Eva Anton, PhD, professor of cell biology and physiology at UNC-Chapel Hill

Source:

Journal reference:

Guo, J., et al. (2019) Primary Cilia Signaling Promotes Axonal Tract Development and Is Disrupted in Joubert Syndrome-Related Disorders Models. Developmental Cell. doi.org/10.1016/j.devcel.2019.11.005.

More:
Research finds key reason why brain connectivity goes awry in rare neurodevelopmental conditions - News-Medical.net

Peter Snell, Record-Breaking Runner in the 1960s, Dies at 80 – The New York Times

Peter Snell, a middle-distance runner from New Zealand who set world records in five events and became a three-time Olympic gold medalist in the 1960s, died on Thursday at his home in Dallas. He was 80.

His wife, Miki, confirmed the death to The New Zealand Herald. She said that he had had a longstanding heart ailment.

Snell was a virtual unknown on the international track scene when he surged in the stretch of the 800-meter race at the 1960 Rome Olympics to overtake Roger Moens of Belgium, who held the world record at the time.

I went to Rome hoping to make the final, Snell was quoted as saying in SunMedia, a conglomerate of newspapers in New Zealand. It was hard to believe that suddenly I was an Olympic champion. I recall looking up to the giant results board above the track and seeing P G Snell NZL at the top of the list. That was one of the great thrills of my life.

Murray Halberg, also from New Zealand, won the 5,000-meter race on the same day that Snell took the 800 meters.

Snell won both the 800 meters and the 1,500 meters at the 1964 Tokyo Olympics, matching a record for gold in those events in a single Olympics that had been set by Albert Hill of Britain at the 1920 Antwerp Games. No one has achieved that feat since Snells double.

In January 1962, racing at Whanganui, in New Zealand, Snell ran a mile in 3 minutes 54.4 seconds, breaking the world record held by Herb Elliott of Australia by one-tenth of a second. He eclipsed his own record by three-tenths of a second in November 1964, this time in Auckland. Hicham El Guerrouj of Morocco, who ran the mile in 3:43.13 at Rome in 1999, is the current record-holder.

Snell also set world records for 800 meters, 880 yards and 1,000 meters, and as a team member in the 4x1-mile relay. He won gold medals at 880 yards and the mile at the British Empire and Commonwealth Games in Perth, Australia, in 1962.

But for all the acclaim he had received internationally, he chose to settle in the United States in the 1970s and live a quiet life working at a research center in Dallas, where he focused on the effects of aerobic exercise on cardiac health.

Peter George Snell was born on Dec. 17, 1938, in the New Zealand beach town of Opunake, to George and Margaret Snell. His father was an electrical engineer.

He excelled at many sports as a teenager and at 19 began working with the prominent middle-distance and long-distance trainer Arthur Lydiard, a New Zealand coach who emphasized slow but grueling long-distance training runs to build stamina. Snell, who was 5-foot-10 and powerfully built, ran up to 100 miles a week in training for the Olympics.

I dont think tactics count too much above simple common sense, he told The New York Times in 1965, his last year on the international racing circuit. Conditioning is the main factor, and determination makes you get in good physical condition.

After retiring from competitive racing, Snell worked in sports promotions for the tobacco company Rothmans International, making speeches and giving clinics at a time before such sponsorships became a matter of controversy.

Rothmans had sent me on a years sabbatical to London in the 1970s, and I wound up reading all this scientific literature, he told The Dallas Morning News in 1983. I got hooked. I really changed. I came back to New Zealand and worked for another year or so, after that realizing that I really wanted to change my career.

Snell earned a bachelor of science degree in human performance from the University of California, Davis, and a doctorate in exercise physiology from Washington State University. In 1981 he became a research fellow at the University of Texas Southwestern Medical Center in Dallas.

He later became an associate professor at the university and was director of its Human Performance Center.

He said that he really wanted to know what made athletes tick and that he hoped to understand why Arthur Lydiards training methods worked so well, he wrote in Peter Snell: From Olympian to Scientist (2007), a collaboration with Garth Gilmour.

He found that it would be easier to do that sort of work out of the spotlight, in America.

There are big advantages in being able to be anonymous; and one of them is that you have to rely on your other attributes in order to make progress and achieve things, he told the magazine New Zealand Listener in 2004. If I was still living here in New Zealand Id be tending to think that I deserved to be given things or treated differently or whatever.

In addition to his wife, whom he married in the early 1980s, Snells survivors include two daughters, Amanda and Jacqui, from his first marriage, which ended in divorce.

In 2009 Snell was knighted by New Zealand, and in 2012 he was one of 24 inaugural members of the International Association of Athletics Federations Hall of Fame.

Go here to read the rest:
Peter Snell, Record-Breaking Runner in the 1960s, Dies at 80 - The New York Times

Your Constant Feeling of ‘Being Tired’ Could Be Due to a Serious Health Problem – ScienceAlert

Tired? Join the club.

Feeling tired or fatigued is a common experience. Yet health-care providers often dismiss complaints about tiredness - both because the symptom is universal and because it can be challenging to evaluate medically, says Michael Grandner, director of the University of Arizona's Sleep & Health Research Program in Tucson.

And while tiredness is often temporary, treatable or nothing to worry about, experts say that tiredness that suddenly worsens or prevents you from doing what you want can be a sign of a health problem or sleep disorder.

"Sleep seems to be a canary in the coal mine, where it's sensitive to all these things going on in your body," Grandner says.

"So, when it starts changing, you want to ask, 'Well, what's going on?'"

Sleepiness, fatigue, tiredness: in conversation, people use the terms interchangeably. But medically, their definitions differ. Understanding the differences is an important first step toward tackling the problem - or figuring out if there is one.

Sleepiness is a need for sleep that makes it difficult to stay awake, even while driving, working or watching a movie, and even after ingesting caffeine.

Fatigue, on the other hand, is a deeper sort of an inability, either physical or mental, to do what you want to do, such as get to the grocery store.

Somewhere in the middle is tiredness, a desire to rest that is less debilitating than fatigue and less dramatic than sleepiness. You can still be productive while tired.

Whatever you call it, it's common. In a 2014 survey by the nonprofit National Sleep Foundation, 45 percent of adults said they had been affected by poor sleep or not enough sleep in the previous week.

As many as 20 percent of people report excessive sleepiness on a regular basis. And, a National Safety Council survey reported in 2017 that 76 percent of people felt tired at work.

If you're bothered by how tired you feel, there might be some simple explanations, including the most basic: not enough sleep. A third of Americans don't get the recommended seven or more hours a night, according to the Centers for Disease Control and Prevention. And because needs vary widely, even seven hours isn't enough for many people.

"If you're routinely getting five or six hours of sleep and you're feeling tired," Grandner says, "that's an easy thing to check off the list in terms of figuring out what the problem is."

Sleep deprivation is not just a nuisance. It raises the risk for car accidents and has been linked with health concerns such as Type 2 diabetes, cardiovascular disease and depression.

Lack of sleep can also affect mood and relationships in ways that even caffeine can't remedy, says Nathaniel Watson, director of the Harborview Sleep Clinic at the University of Washington in Seattle. "There is no substitute for sleep," he says.

Beware the temptation to lie down exactly seven hours before your alarm is set to go off. Nobody sleeps 100 percent of the time that they're in bed, Watson says, so it might take eight hours of pillow time to get seven hours of sleep.

The physiology of sleep might also be getting in your way, if only temporarily. A phenomenon called sleep inertia, for example, is what helps you fall back asleep after ordinary night wakings, which typically happen multiple times a night, Grandner says.

But sleep inertia will also make it tough to get up in the morning if the alarm rings during a deep stage of sleep. That grogginess should wear off within half an hour of pushing through it.

Also normal are occasional rough nights because of stress or sleep interruptions. And even if you get a good night's rest, you may experience a mid-afternoon bout of sleepiness as a result of ordinary circadian rhythms.

Age is something else to keep in mind, though the evidence there is somewhat counterintuitive. Studies show that, as people get older, sleep patterns tend to change in predictable ways. It may start taking longer to fall asleep. You may wake up more often and spend more time awake in the night. And bedtimes and mornings may shift earlier. Menopause is another common cause of interrupted sleep.

But sleep satisfaction doesn't necessarily drop with age. Studies by Grandner and others have found that complaints about sleep and tiredness actually decline with age after a peak in early adulthood. In other words, you should not blame aging if you find yourself struggling with tiredness.

"Aging is associated with sleep that is a little shallower and a little more broken up, but not less satisfying," Grandner says. "If you're an older person and you're really unhappy with your sleep, that's actually an issue."

For people of any age, if tiredness is making it hard for you to get through most days or otherwise getting in your way, experts suggest visiting a primary-care clinic first to be evaluated for common causes of fatigue or tiredness, including depression, autoimmune diseases, vitamin levels and thyroid issues.

One warning: The appointment might be frustrating. Many doctors lack training in sleep medicine, Watson says. Primary-care physicians don't routinely ask patients about sleep, Grandner adds.

They also often miss the signs of insomnia or they suggest ineffective treatments for it, a 2017 study found. Insomnia affects up to 15 percent of adults and, Grandner says, studies show that behavioral therapies work better than medication.

A friend of mine, a parent of a young child, told me that her doctor laughed at her when she mentioned she was tired all the time, as though that was a given at her stage in life.

Anecdotally, though, doctors' visits can turn up all sorts of conditions. Friends have told me about tiredness that led to diagnoses of iron deficiency, fibromyalgia, celiac disease, encephalitis and more.

If nothing turns up in the regular clinic, it's worth seeing a sleep specialist, whose evaluation is likely to include screening for sleep apnea. The disorder, which causes people to periodically stop breathing in their sleep, affects up to 10 percent of adults - with rates higher for people who are overweight. Most don't know they have it. About 85 percent of people who have sleep apnea are undiagnosed and untreated, Watson says.

Bottom line, experts say: Being tired is worth paying attention to. The good news is that causes are often treatable.

"If you're feeling sleepy and it's interfering with your life, you shouldn't just think this is normal kind of a thing," Watson says. "We need to realize that if we prioritize sleep, we become the best version of ourselves."

2019 The Washington Post

This article was originally published by The Washington Post.

Read the original here:
Your Constant Feeling of 'Being Tired' Could Be Due to a Serious Health Problem - ScienceAlert